Cargill confirms signing of agreement with DSM on sale of cultures and enzymes business
6 December 2012: Cargill has completed the sale of its cultures and enzymes business to Royal DSM. All antitrust clearances have been obtained and the transaction was completed on 6 December 2012.
Mechelen, Belgium – 26 October 2012. Cargill confirms that it has signed an agreement to sell it cultures and enzymes business to Royal DSM, the global life sciences and materials sciences company, in an all cash transaction for a total enterprise value of € 85 million. This news follows earlier announcements from both companies that they were in exclusive discussions.
The transaction which is subject to regulatory approval is expected to be completed in the next few months.
This sale is in line with Cargill’s strategy to re-focus its texturizing business and concentrate on product lines that are adjacent to the company’s core activities and where it can be a leading or relevant player in the marketplace.
|Corinne Holtshausen: +44 1932 861174|
- ends -
Notes for editors:
Cargill is an international producer and marketer of food, agricultural, financial and industrial products and services. Founded in 1865, the privately held company employs 142,000 people in 65 countries. Cargill helps customers succeed through collaboration and innovation, and is committed to sharing its global knowledge and experience to help meet economic, environmental and social challenges wherever it does business.
For more information, visit http://www.cargill.com.